Tower Research Capital (TRC)’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6K | Buy |
3,263
+2,256
| +224% | +$20.5K | ﹤0.01% | 3405 |
|
|
2025
Q1 | $9.61K | Sell |
1,007
-41
| -4% | -$391 | ﹤0.01% | 3752 |
|
|
2024
Q4 | $11.8K | Buy |
1,048
+415
| +66% | +$4.66K | ﹤0.01% | 3679 |
|
|
2024
Q3 | $9.1K | Buy |
+633
| New | +$9.1K | ﹤0.01% | 3906 |
|
|
2024
Q2 | – | Sell |
-530
| Closed | -$10.6K | – | 5806 |
|
|
2024
Q1 | $10.6K | Sell |
530
-906
| -63% | -$18.1K | ﹤0.01% | 3684 |
|
|
2023
Q4 | $15.1K | Buy |
1,436
+140
| +11% | +$1.47K | ﹤0.01% | 3838 |
|
|
2023
Q3 | $11.5K | Buy |
1,296
+68
| +6% | +$601 | ﹤0.01% | 3992 |
|
|
2023
Q2 | $11.8K | Buy |
1,228
+127
| +12% | +$1.23K | ﹤0.01% | 3902 |
|
|
2023
Q1 | $15K | Buy |
1,101
+1,049
| +2,017% | +$14.3K | ﹤0.01% | 3785 |
|
|
2022
Q4 | $1K | Buy |
+52
| New | +$1K | ﹤0.01% | 5599 |
|
|
2022
Q3 | – | Sell |
-1,291
| Closed | -$11K | – | 6218 |
|
|
2022
Q2 | $11K | Buy |
1,291
+796
| +161% | +$6.78K | ﹤0.01% | 4372 |
|
|
2022
Q1 | $10K | Sell |
495
-401
| -45% | -$8.1K | ﹤0.01% | 4305 |
|
|
2021
Q4 | $22K | Buy |
896
+649
| +263% | +$15.9K | ﹤0.01% | 3562 |
|
|
2021
Q3 | $10K | Sell |
247
-41
| -14% | -$1.66K | ﹤0.01% | 4315 |
|
|
2021
Q2 | $13K | Sell |
288
-1,565
| -84% | -$70.6K | ﹤0.01% | 4221 |
|
|
2021
Q1 | $63K | Buy |
+1,853
| New | +$63K | ﹤0.01% | 2929 |
|